Viking Therapeutics, Inc. Annual Return On Assets in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Viking Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2015 to 2023.
  • Viking Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -14.5 %, a 56.6% increase year-over-year.
  • Viking Therapeutics, Inc. annual Return On Assets for 2023 was -26.4 %, a 31.9% increase from 2022.
  • Viking Therapeutics, Inc. annual Return On Assets for 2022 was -38.7 %, a 62.4% decline from 2021.
  • Viking Therapeutics, Inc. annual Return On Assets for 2021 was -23.8 %, a 61.1% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -26.4 +12.3 +31.9% Jan 1, 2023 Dec 31, 2023
2022 -38.7 -14.9 -62.4% Jan 1, 2022 Dec 31, 2022
2021 -23.8 -9.04 -61.1% Jan 1, 2021 Dec 31, 2021
2020 -14.8 -5.96 -67.6% Jan 1, 2020 Dec 31, 2020
2019 -8.82 +1.78 +16.8% Jan 1, 2019 Dec 31, 2019
2018 -10.6 +119 +91.8% Jan 1, 2018 Dec 31, 2018
2017 -130 -35 -36.9% Jan 1, 2017 Dec 31, 2017
2016 -94.8 +62.6 +39.8% Jan 1, 2016 Dec 31, 2016
2015 -157 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.